Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07288437
NA

Deep Brain Stimulation for Spinocerebellar Ataxia

Sponsor: University of California, San Francisco

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to test the safety of placing Deep Brain Stimulators (DBS) in the cerebellum and using electrical stimulation of that part of the brain to treat symptoms related to the participants spinocerebellar ataxia. Five adults diagnosed with spinocerebellar ataxia type 6 (SCA6) with inadequate cerebellar symptom relief will be implanted with a Medtronic Percept Primary Cell Neurostimulator. The device will be implanted into the dentate nucleus, which is a structure located within the cerebellum that is responsible for controlling movement and balance. Specifically, the investigators will be using adaptive deep brain stimulation (aDBS), which analyzes brain signals and automatically adjusts the strength, timing, and pattern of stimulation according to the patient's needs at any given moment. This study will evaluate the feasibility, safety, and tolerability of aDBS in SCA6 patients.

Official title: Adaptive Deep Brain Stimulation Targeting the Dentate Nucleus to Treat Spinocerebellar Ataxia

Key Details

Gender

All

Age Range

21 Years - 89 Years

Study Type

INTERVENTIONAL

Enrollment

5

Start Date

2026-03

Completion Date

2031-03

Last Updated

2026-03-18

Healthy Volunteers

No

Interventions

DEVICE

Deep Brain Stimulation (DBS)

This device will be surgically implanted into the dentate nucleus of the cerebellum.

Locations (2)

UCSF Weill Institute for Neurosciences

San Francisco, California, United States

University of California, San Francisco

San Francisco, California, United States